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In addition to the obvious differences in body shape, there are substantial differences
in lipid metabolism between men and women. These differences include how dietary
fatty acids are handled, the secretion and clearance of very low-density lipoprotein-
triglycerides, the release rates of free fatty acids (FFA) from adipose tissue relative to
energy needs, and the removal of FFA from the circulation, including the storage of FFA
into adipose tissue via the direct uptake process. We will review what is known about
these processes and how they may contribute to the sexual dimorphism of body fat
distribution.
Keywords: sex steroids, estrogen, testosterone, sex hormone, metabolism, fatty acid, lipids
Introduction
Where we store fat in our bodies is a significant predictor of metabolic disease risk. Metabolic
diseases predominantly affect people with an upper body/android fat distribution compared to
those with a lower body/gynoid distribution (1). Jean Vague was the first to report the relationship
between “android” obesity and diabetes (2). Since that report, numerous studies have confirmed the
relationship between central adiposity and risk of diabetes (3, 4), cardiovascular disease risk and
events (5, 6), hypertension (7), sleep apnea (8), cancer (9), and overall mortality rates (10); men
and women in the highest quintile of measured waist circumference (WC) are reported to have
almost twice themortality rates than those in the lower quintiles. Thoughwe do not fully understand
why people are shaped differently, one of the most obvious factors determining body shape is sex
hormone status.
Healthy, modestly active/sedentary women with BMIs of 20–25 kg/m2 often have 25–35% body
fat, whereas men of the same BMI have 10–20% body fat; highly athletic women and men can
have less body fat (11). Typical non-obese adult males have little leg fat relative to upper body fat
and most non-obese, premenopausal adult females have ample lower body fat stores and limited
visceral adipose tissue (VAT). In contrast, men have greater amounts of VAT, even controlling for
body fat mass, and VAT constitutes a greater proportion of total fat mass in men than women,
especially at higher BMIs (12). The mechanisms underlying the sexual dimorphism in body fat
and its distribution between men and women are not well understood. Studies that investigate the
contribution of lipidmetabolism to body shape indicate a staunch effect of sex steroids. The objective
of this review is to examine how lipid metabolism contributes to differences in body fat distribution
and the role of sex hormones in modulating these differences.
Fatty Acid Metabolism
The principle function of adipose tissue is to store and release FA in response to changes in energy
balance. Following consumption of a fat containing meal, a significant proportion of circulating
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chylomicron-triacylglycerol (TAG) fatty acids (FA) is stored via
lipoprotein lipase (LPL) into adipose tissue. In this pathway,
endothelial LPL hydrolyzes FA from the glycerol backbone of
chylomicron-TAG, allowing them to enter the adjacent adipose
tissue. Some of the FAs from chylomicron-TAG are not taken up
locally, but instead “spillover” into systemic circulation. A less
appreciated pathway of FA storage occurs via the direct re-uptake
of free fatty acids (FFA) from the systemic circulation independent
of the LPL mechanism. Although we typically envision that the
FFA released as a result of adipose tissue lipolysis are destined to
supply fuel to lean tissues for fat oxidation, a portion is taken up
and stored in distant adipocytes. We have referred to this process
as direct FFA storage.
In addition to LPL, there are a number of other proteins and
enzymes that are involved in adipose tissue FAmetabolism.When
it comes to FA entry into cells, FA can be taken up by passive
(flip–flop) diffusion or via membrane protein facilitated diffusion
(13). One of the more closely examined proteins involved in
facilitated diffusion is the FA transport protein CD36. CD36 is a
cell surface glycoprotein that is particularly important when extra-
cellular FA concentrations are reduced (13, 14). CD36 appears
to play a main role in the localization of long chain FA to the
adipocyte membrane through FA binding (13). Recent studies
indicate that CD36 facilitates muscle and adipose tissue FFA
uptake under conditions of reduced FFA availability, whereas hep-
atic FFA uptake appears to be CD36-independent and myocardial
uptake is partially CD36-dependent across a wider range of FFA
concentrations (14). Other proteins that have been investigated in
their role of FA storage are acyl-CoA synthetase (ACS) and diacyl-
glycerol acyl transferase (DGAT). ACS catalyzes the intracellular
activation of the FA to their CoA form (15). DGAT, the final step
of storage of FA asTAG, is suggested to be a rate limiting enzyme in
FA storage (16). There are three enzymes involved in triglyceride
hydrolysis: adipose triglyceride lipase (ATGL), hormone-sensitive
lipase (HSL), and monoglyceride lipase (MGL) (17). Of these
three enzymes, HSL has been the most studied and has been
linked to aberrations in lipolysis associated with obesity (18). HSL
hydrolyzes an assortment of substrates including TAG, diacyl-
glycerol, and monoacylglycerol (17). We have postulated that the
activity of proteins involved in FA storage and lipolysis play key
roles in modulating regional fat distribution.
The relative and absolute size of the different adipose tissue
depots is ultimately determined by the balance between lipolysis
on one hand and storage of FA from chylomicrons, very low-
density lipoprotein (VLDL), and direct FFA uptake on the other.
Although other factors, such as the gain or loss of lean tissue and
changes in endocrine signaling, impact body composition, this
review will focus on studies that examine the contributions of FA
metabolism in determining regional body composition. Several
studies have been conducted to expand our understanding of how
the variation in body fat distribution in men and women relate to
systemic and regional fat metabolism.
Lipid Metabolism in Men and Women
Figure 1 summarizes the findings in lean men vs. age- and BMI-
matched premenopausal women for each aspect of FAmetabolism
discussed below.
FIGURE 1 | Summary of relative FFA metabolism in young, lean, fasted
men, and age- and BMI-matched fasted premenopausal women.
Fatty Acid Oxidation
In the postprandial and postabsorptive state, FA oxidation does
not appear to be different between men and women whereas
during exercise fat oxidation is higher in women. This is because
there are several factors other than sex that are potential indepen-
dent contributors toward the variations in fat oxidation between
individuals including energy balance, age, heredity, and body
composition (19). Because fat oxidation has been shown to relate
to fat free mass (FFM), and because men and women of the same
weight often differ with regards to body composition, comparing
fat oxidation in milligrams per minute or milligram per kilogram
per minute may be misleading. In determining whether there are
differences in fat oxidation between sexes, FFM can be accounted
for by statistical adjustment or fat oxidation can be expressed
in the context of total energy expenditure (as RQ or a percent).
Unless men and women are matched for FFM, we prefer not to
express substrate oxidation divided by FFM per unit time. This
is because the relationship between energy expenditure and FFM
is not ratio-standard; that is, the intercept is not zero and the
slope is not 1. On average at a given energy expenditure (substrate
oxidation), individuals with lower FFM will de facto have greater
energy expenditure per kilogram FFM than those with greater
amounts of FFM.
When the results of tracer studies were integrated, it was sug-
gested that over a day that includes 2 h of exercise, 14 h in the
postabsorptive state, and 8 h in the postprandial state, fat oxida-
tion was similar in men and women (20). This conclusion was
supported by a study that measured 24 h RQ in a whole room
calorimeter that included spontaneous physical activity, which
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found no differences between men and women (19). The lack of
a difference in fat oxidation between men and women remains
after adjusting for FFM during rest (21) or during a 24 h period
with the incorporation of light–moderate physical activity (22).
However, it should be noted that it is difficult to draw conclusions
based on these and the following studies discussed herein for lack
of appropriate statistical adjustment for FFM. In contrast, a whole
room calorimeter study byMelanson et al. (23) found that women
had 24–56% greater 24 h fat oxidation (milligram fat oxidation
per kilogramFFM) thanmen, regardless of physical activity levels.
Women in the study also had an enzymatic profile that favored β-
oxidation in muscle (23). A review by Henderson (24) concluded
that men oxidize more fat than women in the post-exercise state
provided that they remain fasting. However, if food is ingested,
this difference is no longer present. Additionally, with aging,
changes in sex steroid concentrations may impact fat oxidation,
as fat oxidation (rather than glucose oxidation) was observed to
decrease in proportion to energy expenditure (21). Hober et al.
(25) showed that with increasing age inmales, resting fat oxidation
(gram per kilogram lean mass) decreases whereas in females, no
relationship was observed between resting fat oxidation and age.
Thus, fluctuations in sex hormones as a result of age may be
partially responsible for differences in fat oxidation between men
and women.
Very Low-Density Lipoprotein TAG Kinetics
In the fasting state, most circulating plasma TAG are in VLDL,
which are synthesized and secreted by the liver (26). Similar to
chylomicron-TAG, VLDL-TAG are hydrolyzed by LPL residing
on the capillary endothelium, making FA available to the under-
lying tissue for energy or storage. It is well established that men
have higher circulating VLDL-TAG than age-matched women
(27), but the etiology of this sex difference is not completely
understood. Lean women have both greater VLDL-TAG secretion
and clearance compared with lean men (28), which causes us
to favor greater relative removal of VLDL-TAG as the primary
explanation. In obesity, increased rates of VLDL-TAG secretion
and decreased rates of VLDL-TAG clearance in men vs. women
have been reported (28, 29).
Meal Fatty Acid Storage
Patterns of meal FA storage only somewhat mirror the patterns
of regional fat distribution. We initially found no differences in
patterns of meal FA storage in men and women; more meal FAs
were stored (per gram lipid) in upper body SAT than in leg SAT in
both groups (30–32). However, following consumption of a high-
fat meal, women stored a greater proportion of meal fat in lower
body SAT whereas men did not (33). Moreover, when meal FA
storage was compared in men and women with different obesity
phenotypes, variations in regional meal fat storage were found
(34). In women with lower body obesity, meal FA storage was
greater in gluteal than abdominal fat (34), whereas storage was
similar in these two depots in upper body obese men and women.
Furthermore, upper body obese men stored a lesser percent of
meal fat in subcutaneous fat than either group ofwomen (34). This
suggests that meal FA storage may play a role in determining the
sex differences in regional adiposity.
Direct FFA Storage
Even more so than meal FA storage, patterns of circulating FFA
storage (termed, “direct FFA storage”) correspond to the sexual
dimorphism in fat distribution. When the direct FFA storage
pathway was first reported, FFA storage into SAT was consistent
with body shape in men and women. More specifically, direct
FFA storage in SAT was less in men than women, and men
stored more FFA in abdominal vs. femoral SAT depots whereas
women did not (35). Follow-up studies confirmed these results
and noted that FFA storage rates were greater in femoral than
abdominal SAT in women (36). In women with varying regional
fat distribution, direct storage of FFA also followed regional fat
distribution (37). These studies support a role of direct FFA
storage as a means of redistributing FAs in a manner that appears
to influence body shape.
Lipolysis
If rates of lipolysis were amajor contributor toward sex differences
in AT deposition, we would expect sex differences in the relative
rates of total and regional lipolysis in men compared to women.
For example, since women have greater lower body fatmass, lower
rates of leg adipose tissue lipolysis would be observed in women
compared with men. However, we found that the opposite is true.
We found that leg adipose tissue lipolysis rates were 44µmol/min
in lean and 107µmol/min in obese men, and 61µmol/min in lean
and 107µmol/min in obese women. Thus, lipolysis in leg SAT of
men and women was approximately equal, and even a little higher
in lean women vs. men (38). Moreover, studies collectively show
that regardless of sex, upper body AT is more lipolytically active
than lower body (38–42). Therefore, lipolysis does not appear to
explain the sexual dimorphism seen in body fat distribution.
The Effect of Estrogen and Testosterone on
Lipid Metabolism
The sexual dimorphism in adiposity along with differences in fat
metabolism found in men and women allude to a compelling role
of sex steroids in determining regional fat distribution. Several
studies have examined the effects of sex steroid suppression and/or
supplementation on fat metabolism. Table 1 summarizes what is
known about the changes in lipidmetabolism that occurs with sex
steroid suppression in men and women.
Fat Oxidation
Periodic 24 h measurements over a 4-year period showed that
fat oxidation did not change in premenopausal women, whereas
in postmenopasual women, fat oxidation decreased 32% (43).
However, significant changes in body composition and diet may
have affected the changes in fat oxidation in these women (43).
We were able to exclude differences in body composition as
the factor influencing fat oxidation in pre- vs. postmenopausal
women by studying two groups of women matched for age, BMI,
and body fat (44). We found that postprandial fat oxidation was
indeed lower in postmenopausal women (44), confirming that
hypogonadism/estrogen deficiency reduces fat oxidation, at least
during a portion of the day. Whether the opposite is true, i.e.
whether estrogen repletion increases fat oxidation, is unclear.
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TABLE 1 | Changes in lipid metabolism as a result of estrogen deficiency in
women and testosterone deficiency in men relative to eugonadal women
and men, respectively.
E T
Fat oxidation # #
VLDL-TAG " =
VLDL-TAG secretion ## =
VLDL-TAG clearance ? ?
Abdominal meal FA storage = =
Leg meal FA storage "" "
Direct FFA SAT storage " =
Lipolysis " =
All symbols compare deficient to eugonadal individuals. " or #, increases or decreases;
"" or ##, large increases or large decreases; =, no differences between deficient and
eugonadal individuals; ?, unclear findings with regards to the effects of sex steroid
deficiency.
When transdermal estrogen is provided to postmenopausal
women over 6months, neither changes in body composition
nor changes in fat oxidation were observed (45). However,
another study that supplemented estrogen transdermally over
a 12-month period observed increases in lipid oxidation. These
women had an increase in lean mass and no changes in fat mass
over the 12-month estrogen repletion period (46). The different
results in these studies could stem from the changes in body
composition that occurred over the treatment period. More
studies are required to tease out whether estrogen repletion in
women affects fat oxidation.
We believe the balance of data suggests that testosterone
increases fat oxidation in men. One study showed that acute
hypogonadism did not change fat oxidation over a 3-week period
compared to men replete with estrogen and/or testosterone (47).
In contrast, Host et al. (48) showed that 1month of hypogo-
nadism decreased fat oxidation. This finding was supported by
another study, which observed that hypogonadism over 10weeks
decreased rates of fat oxidation; however, decreases in fat free and
increases in fat mass may partially explain these changes (49). To
address the potential effect of body composition on fat oxidation,
we matched chronically hypogonadal males for age and body
composition and found lower fat oxidation in hypogonadal vs.
eugonadal males (50). Four months of testosterone treatment in
adolescent males with delayed puberty resulted in an increase in
fat oxidation (51). Although 2 years of transdermal testosterone
supplementation in elderly men with modestly reduced testos-
terone did not change body composition or meal fat oxidation,
these men were not truly hypogonadal (52).
VLDL-TAG Kinetics
Studies examining the effects of sex hormones on VLDL-TAG
kinetics in men and women do not appear to clarify the lower
VLDL-TAG concentrations in women. VLDL-TAG secretion in
premenopausal women was found to be twice that of post-
menopausal women despite higher VLDL-TAG concentrations in
postmenopausal women (29). In another study, women treated
with estradiol vs. progesterone vs. testosterone vs. control were
compared (53). VLDL-TAG kinetics did not change with placebo,
or progesterone or testosterone treatment but clearance increased
in the estrogen-treated group in conjunction with decreased
VLDL-TAG concentrations (53). There were no differences in
VLDL-TAG secretion in any of the groups of the study (53).
The finding that testosterone supplementation in women did not
affect VLDL kinetics was consistent with that of another study by
the same group that supplemented testosterone in obese women
for 3weeks (54). In men, 1month of hypogonadism and acute
testosterone repletion to physiological levels did not affect VLDL-
TAG secretion and concentrations (48).
Meal FA Storage
Few studies have been conducted to examine the effects of estro-
gen on meal FA storage. We found that postmenopausal had
greatermeal FA storage than premenopausal women (44).We also
found that, compared to premenopausal women, meal FA storage
in the femoral depot was two times greater in postmenopausal
women (44). Another study that used LPL as a surrogate for meal
FA storage observed that in postmenopausal women treated with
estrogen and progesterone, LPL activity was higher in femoral vs.
abdominal adipocytes (55). These studies indicate that estrogen
affectsmeal FA storage in such away as to promotemeal fat storage
in lower body fat in women. Why postmenopausal women would
thus tend to gain abdominal fat is unclear.
There have been a limited number of studies on the effects of
acute or chronic testosterone hormonal manipulation on meal FA
metabolism. We found that chronically hypogonadal men stored
more meal FA in the femoral region than eugonadal men (50).
Whereas meal FA storage (milligram per gram lipid) in hypog-
onadal men was similar in the abdominal and femoral region,
eugonadal men tended to store more meal FA in the abdominal
than thigh region (50). These patterns of fat storage would be
consistent with what we would expect given the regional differ-
ences in fat distribution between hypogonadal and eugonadal
men. Thus, testosterone likely affects regional adiposity through
its effects on regional meal FA storage. We did find that 2 years
of testosterone supplementation of older men with somewhat
reduced testosterone concentrations increased meal FA storage in
the abdominal vs. femoral region (52). In another study, acute
(5 days) of testosterone treatment decreased meal FA storage in
VAT (30). In contrast,Marin et al. (31) found at baseline thatmore
meal FA was stored in the abdominal vs. femoral depot and that
after 9months of testosterone treatment, these differences in meal
FA storage no longer existed (31). This shift was likely because of a
significant decrease in meal FA storage in abdominal SAT with T
treatment. Potential reasons for this contradictory finding could
stem from differences in ages of men between studies, differences
in the testosterone treatment period, or differences in the timing
of biopsies after ingestion of the experimental meal (56).
Direct FFA Storage
We matched pre- and postmenopausal women for age and body
composition and found that direct FFA storage was greater in
postmenopausal than premenopausal women (44). However, we
found no significant regional differences in the storage of FFA
between these two groups (44). A closer examination of the
key factors involved in FFA storage showed that activity of ACS
and DGAT were significantly upregulated in postmenopausal
compared to premenopausal women indicating greater potential
for FFA storage in postmenopausal women. In a second study, we
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found no differences in the rates of FFA storage between age and
body composition match men who were chronically hypogonadal
and eugonadal (50). However, activity of ACS was significantly
greater in femoral adipose tissue of eugondal than hypogonadal
men. The effects of sex steroids on direct FFA storage remains to
be investigated before a conclusion can be drawn.
Lipolysis
Although regional differences in the relative rates of lipolysis are
unlikely to be central in determining regional fat differences in
men and women, there are major differences in rates of lipol-
ysis relative to energy expenditure (38, 39). The rates of FFA
release are ~40% greater in women than men relative to energy
needs (38), despite similar relative rates of fat oxidation. Studies
that manipulate sex steroids in humans support this conclusion.
Contrary to what would be expected, decreases in sex steroids
increase lipolysis whereas no differences in lipolysis occur with
hormone treatment. Estrogen deficiency in women resulted in
a 10–20% increase in lipolysis whereas estrogen repletion did
not affect adrenergic stimulated lipolysis (57). This finding is
consistent with that of another study, which showed that estrogen
and progesterone treatment in postmenopausal women did not
affect lipolysis (55).
Testosterone treatment has been shown to decrease total and
abdominal fatmass and thus, would be expected to increase lipoly-
sis. Testosterone treatment has been shown to stimulate lipolysis in
the abdominal region (55) and in VAT (58). However, these cited
studies involved shorter treatment periods. Another short-term
study found that 7–10 days of hypogonadism and acute testos-
terone rescue did not have any effects on indicators of adipose
tissue lipolysis (48). These findings are consistent with a longer
2-year period of testosterone treatment in hypogonadal men that
did not detect any changes in lipolysis from upper or lower body
SAT (52). Moreover, whole-body lipolysis was also found to be
unchanged in adolescent males after 4 months of testosterone
treatment (51).
Conclusion
The objective of this review was to describe the differences in
lipid metabolism between males and females and to link, when
possible, these differences to how they may cause or create the
differences in body shape. Subsequently, we also sought to explore
how sex steroids regulate this relationship. Fat oxidation, lipolysis,
VLDL-TAG, meal FA metabolism, and direct FFA storage may
collectively contribute toward total and regional adiposity. Sev-
eral studies have been conducted to examine these aspects of fat
distribution in the context of differences in sex and sex steroids.
Regional meal FA and direct FFA storage appear to contribute
toward the sexual dimorphism in fat distribution.While the extent
to which fat oxidation andVLDL-TAGkinetics contribute to body
composition are unclear, it is evident that lipolysis has little effect
in contributing toward differences in body shape between men
and women.
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